Results 251 to 260 of about 8,806,695 (362)

Understanding Creative Consumers: Implications For Intellectual Property And Brand Management

, 2016
Karen Robson
openalex   +1 more source

How contribute strategic corporate brand management model? : Thai SMEs context

, 2017
Pongsiri Kamkankaew, Phithagorn Thanitbenjasith, Suteera Sribenjachote   +2 more
openalex   +2 more sources

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

Marketing Strategies and Factors Influencing the Popularity of Alcohol Videos from Official Brand Accounts on Douyin: Content Analysis Study. [PDF]

JMIR Infodemiology
Zhao Y, Zhang L, Qian C, Guo W, Zhu W, Zheng P.   +5 more
europepmc   +1 more source

Neuropsychiatric Symptoms Mimicking Dementia in a Patient Treated With Imatinib

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Tyrosine kinase inhibitors are the cornerstone of chronic myeloid leukemia treatment. Newer agents have more potency and a broader spectrum of action, but also a higher potential for neuropsychiatric side effects. We present a case of a patient on imatinib who developed progressive cognitive, mood, and behavioral alterations.
Ashley Jones, Samuele Bonomi, Keith E. Stockerl‐Goldstein, Randall J. Bateman   +3 more
wiley   +1 more source

Trends in utilization and cost of triglyceride-lowering therapies among Medicare beneficiaries: An analysis from the Medicare part D database. [PDF]

Am J Prev Cardiol
Malkani K, Zhang R, Sobti N, Zachariah K, Groenendyk J, Purkayastha S, Ying X, Newbury D, Steitieh D, Patel S, Kini V.   +10 more
europepmc   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Prior Authorization, Quantity Limits, and Step Therapy for Patient-Administered Antiemetics.

JAMA Netw Open
Vu K, Gupta A, Chino F, Barnes J, Thom B, Kyle MA.   +5 more
europepmc   +1 more source

The Evolution of Medical Affairs Central Teams: Shaping Strategic Action and Driving Healthcare Transformation Through Scientific Interaction. [PDF]

Pharmaceut Med
Leal Beckouche M, Resler Plat G, Marinich JA, Moreno C, Moreno M, Gostkorzewicz J, Iglesias I, Pérez Domínguez A.   +7 more
europepmc   +1 more source

THE ESSENCE OF BRAND MANAGEMENT AND ITS IMPACT ON CORPORATE SUCCESS

, 1996
Rasim Abutalibov, Kh.Kh Nurullayev
openalex   +1 more source